Home > Insider Trading > Filing (0001125345-19-000018)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1125345	Macrogenics Inc	MGNX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1397266	K Matthew Fust	9704 Medical Center Drive Rockville MD 20850		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-02-06	6,924	$20.15	7,424	No	4	M	Direct
Common Stock	Disposition	2019-02-06	6,924	$29.38	500	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2019-02-06	6,924	$0.00	6,924	$20.15

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2014-07-05	2024-06-05	No	4	M	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2018.
The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $29.23 to $29.73. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares purchased at each price within the range.